ArticleCancers2021

HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells.

Katharina M Ewers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.